CLAIM #58519 · UnitedHealth Group Incorporated (UNH) · 2022Q1 earnings call · Apr 14, 2022 · due Dec 31, 2024
“And then longer term kind of moderating in the mid-single digits, and that's really that relentless focus on pushing the value and from the pharmacy services into our clients and into our patients and our clients' consumers and making sure that we continue to drive the tools and services that our clients will pay for.”
Heather Cianfrocco · Executive
In context
“y benefit business, but also the pharmacy services and the direct-to-consumer. So that will continue to support our top line growth. That will support that retention and continued growth -- membership growth in the PBM. But in addition, those pharmacy services become increasingly important as we look at the future in these coming years, you're right, there's -- as we look long anticipated introduction of multiple opportunities in biosimilar and other specialty services for our members. The services that we offer through our pharmacy services programs are really, I think, going to drive not just the growth in our -- the top line of our business, that continued push in our earnings, which as committing to our guidance for this year, which you see it as a mid- to high actually single-digits. And then longer term kind of moderating in the mid-single digits, and that's really that relentless focus on pushing the value and from the pharmacy services into our clients and into our patients and our clients' consumers and making sure that we continue to drive the tools and services that our clients will pay for. Those are our clients, our external book of clients, our UnitedHealthcare client, and that's also our pharmacy services clients like our community pharmacy clients, which really need services and offerings like our behavioral health services that really integrate a fragmented system. So I look at the whole thing. And as we move forward, the tools like our clinical analytics, our PBM, our specialty program management services that were referenced in by Andrew early in our script this morning, as well as our continued push to transform using our pharmacists as the way we're really going to grow our business. Andrew Witty: Great. Heather, thanks so much. And Ricky, thank you very much for the question. We just have time for one last question. So Emma, maybe go to the last question. Operator:”
Verify independently
SEC filings for UNH ↗ · Claim quote is verbatim from the 2022Q1 earnings call.